Document is current
Any future updates will be listed below
-
Authors
Han, Tianyu https://orcid.org/0000-0002-8636-6462
Wu, Riga
Tian, Yu
Khader, Firas
Adams, Lisa C. https://orcid.org/0000-0001-5836-4542
Bressem, Keno K. https://orcid.org/0000-0001-9249-8624
Davatzikos, Christos https://orcid.org/0000-0002-1025-8561
Kather, Jakob Nikolas
Shen, Li https://orcid.org/0000-0002-5443-0503
Mankoff, David A.
Barbosa, Eduardo Mortani Jr
Truhn, Daniel https://orcid.org/0000-0002-9605-0728
- License Information
-
More Information
Article History
Received: 26 September 2025
Accepted: 8 June 2026
First Online: 22 July 2026
Ethics
Competing interests: J.N.K. declares consulting services for AstraZeneca, MultiplexDx, Panakeia, Mindpeak, Owkin, DoMore Diagnostics and Bioptimus. Furthermore, he holds shares in StratifAI, Synagen and Spira Labs, has received an institutional research grant from GSK and has received honoraria from AstraZeneca, Bayer, Daiichi Sankyo, Eisai, Janssen, Merck, MSD, BMS, Roche, Pfizer and Fresenius. D.T. holds shares in StratifAI and Synagen and has received honoraria from AstraZeneca, MSD, Roche, Siemens and Philips. K.K.B. reports speaker fees from Canon Medical Systems and GE Healthcare; and Data Safety Monitoring Board participation for Philips (IHI Project IMAGIO). The other authors declare no competing interests.
